Testosterone replacement therapy should only be prescribed to men who have confirmed testosterone deficiency, and any patient eligible for treatment must also be warned about potential cardiovascular risks, the TGA has said. In a medicines safety update, the TGA says it has received adverse event reports associated with off-label use particularly among ageing men who ...
TGA maintains cautious approach to testosterone replacement therapy
By Sunalie Silva
25 May 2017